Corticosteroids in inoperable malignant bowel obstruction: clinical practice based on limited evidence.

Authors

Jason W Boland, Elaine G Boland

Published in

BMJ supportive & palliative care. Aug 19, 2026. Epub Aug 19, 2026.

Abstract

Corticosteroids are sometimes used in inoperable malignant bowel obstruction (MBO) despite limited evidence. The main randomised evidence comes from an old Cochrane review totalling 89 patients demonstrating a non-significant trend towards obstruction resolution and no survival benefit. Subsequent literature consists of retrospective and uncontrolled studies failing to control for spontaneous resolution, disease heterogeneity and concomitant therapies. Dose, duration and outcomes are inconsistently reported. Corticosteroid toxicities are potentially harmful. Overall, there are no high-quality data to support corticosteroids as a standard therapy in MBO. If a clinician wishes to use in selected patients, this should be as a time-limited therapeutic trial framed within the context of uncertainty.

PMID:
42618343
Bibliographic data and abstract were imported from PubMed on 20 Aug 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.